Obesity treatment and device

• US 7,803,195 B2
• Filed: 05/31/2005
• Issued: 09/28/2010
• Est. Priority Date: 06/03/2004
• Status: Active Grant

• Current Assignee: Mayo Foundation For Medical Education And Research (Mayo Clinic)
• Original Assignee: Mayo Foundation For Medical Education And Research (Mayo Clinic)
• Inventors: Levy, Michael J., Camilleri, Michael L., Sandborn, William J., Murray, Joseph A.
• Primary Examiner(s): HAND, MELANIE JO
• Application Number:
  US11/141,869
• Publication Number:
  US 20050273060A1
• Time in Patent Office: 1,946 Days
• Field of Search: 128/898, 606/108, 604 8- 10, 623/23.64, 623/23.65, 623/23.67, 623/23.68
• US Class Current: 623/23.68
• CPC Class Codes: A61B 17/1114 of the digestive tract, e.g. bowels or oesophagus
• CPC Class Codes: A61B 17/12099 characterised by the location of the occluder
• CPC Class Codes: A61B 17/12136 Balloons
• CPC Class Codes: A61B 2017/1139 Side-to-side connections, e.g. shunt or X-connections
• CPC Class Codes: A61F 5/003 inflatable
• CPC Class Codes: A61F 5/0033 with more than one chamber
• CPC Class Codes: A61F 5/0076 preventing normal digestion, e.g. Bariatric or gastric sleeves
• CPC Class Codes: A61F 5/0079 Pyloric or esophageal obstructions
• CPC Class Codes: A61F 5/0083 Reducing the size of the stomach, e.g. gastroplasty surgical interventions A61B17/00

Abstract

A method and apparatus are disclosed for treating obesity includes an artificial fistula created between gastrointestinal organs such as between the stomach and the colon. The method includes selecting an implant comprising a passageway having an internal lumen with an inlet end and an outlet end. The passageway is positioned passing through a first wall of first gastrointestinal organ (for example, passing through the wall of the stomach) and a second wall of a second gastrointestinal organ (for example, passing through the wall of the large intestine) with the inlet end disposed within an interior of the first gastrointestinal organ and with the outlet disposed within an interior of the second gastrointestinal organ.

Claims

1. A method for treating obesity of a patient having a normal flow path in series through gastrointestinal organs of the patient including a stomach, duodenum, jejunum, ileum and colon, said method comprising:

1) identifying an obese patient for treatment of obesity;

2) positioning an implant,

wherein said implant comprises;

a) a first inflatable chamber,

b) a second inflatable chamber,

c) an internal lumen that defines an artificial passageway having an inlet end adjacent the first expandable chamber and an outlet end adjacent the second expandable chamber, and having one or more inflation lumens in fluid connection with the first inflatable chamber and the second inflatable chamber; and

d) a valve member for controlling a flow of contents through said passageway from said inlet end to said outlet end;

wherein said positioning comprises placing said implant through an artificial opening formed in a wall of said stomach of the obese patient and through an artificial opening formed in a wall of at least a selected one of said duodenum, said jejunum, said ileum and said colon of the patient, with said inlet end disposed within an interior of said stomach and with said outlet end disposed within an interior of said selected one of said duodenum, said jejunum, said ileum and said colon, wherein said artificial passageway of said implant is completely outside of a pylorus of the patient; and

3) securing said inlet end within the interior of the stomach by inflating the first expandable chamber, and securing said outlet end within the interior of said selected one of said duodenum, said jejunum, said ileum and said colon by inflating the second expandable chamber such that said artificial passageway is completely outside of the pylorus of the patient.

2. A method according to claim 1 further comprising sealing an external surface of said passageway at said wall of said stomach and said wall of said selected one of said duodenum, said jejunum, said ileum and said colon.

3. A method according to claim 1 further comprising restricting a flow through said normal flow path of said patient at a location in said flow path proximal to said outlet end.

4. A method according to claim 3, further comprising inserting a flow restrictor into the pylorus of the patient.

5. A method according to claim 1 wherein a size of the passageway is adjusted after positioning of said implant.

6. A method according to claim 1 wherein said valve member is a one-way valve to reduce a likelihood of material movement from the outlet end to the inlet end.

7. A method according to claim 1, wherein the valve member is located within the artificial passageway.

8. A method according to claim 1, wherein the first and second inflatable chambers can be inflated with liquid or gases.

9. A method according to claim 1, wherein the first and second inflatable chambers are toroidal shaped.

10. A method according to claim 1, wherein said implant comprises a first inflation lumen connected to the first inflatable chamber;

and a second inflation lumen connected to the second inflatable chamber.

11. A method according to claim 1, wherein said implant further comprises an inflation port connected to one or more inflation lumens.